Perbedaan Diagnos Laboratorium Utama Tbk. dan Kalbe Farma Tbk: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Kalbe Farma Tbk diperdagangkan di Rp705 (kapitalisasi pasar 34,17 T, volume 24 jam 156,61 jt). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 110× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Kalbe Farma Tbk lebih aktif diperdagangkan (156,61 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | KLBF | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 34,17 T |
Volume | 963,6 rb | 156,61 jt |
Lot | 9,64 rb | 1,57 jt |
Perputaran | 217,67 jt | 111,23 M |
Harga Rata-rata | 225,89 | 710,21 |
Nilai Transaksi | 217,67 jt | 111,23 M |
Harga Ekuilibrium Indikatif | 226 | 705 |
Volume Ekuilibrium Indikatif | 1 rb | 56,1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →